Bronchopulmonary Dysplasia Therapeutics Market Size in the 7MM is expected to grow a significant CAGR by 2034, estimates DelveInsight | Medipost Co, Oak Hill Bio/Takeda, Chiesi Farmaceutici, PNEUMOSTEM, Airway Therapeutics, Emmes Company, Medipost Co Ltd.

DelveInsight's "Bronchopulmonary Dysplasia Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Bronchopulmonary Dysplasia, historical and forecasted epidemiology as well as the Bronchopulmonary Dysplasia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Bronchopulmonary Dysplasia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Bronchopulmonary Dysplasia Market Forecast- https://www.delveinsight.com/sample-request/bronchopulmonary-dysplasia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Bronchopulmonary Dysplasia Market Report
• In February 2025:- Medipost Co. Ltd:- This is a follow-up study to investigate the long-term safety and efficacy of PNEUMOSTEM® versus placebo, for the treatment of BPD in premature infants. Subjects who participated in and completed the initial stage of the Phase II trial (NCT03392467) will be followed-up until 60 months of corrected age
• According to the DelveInsight analysis, in 2023, approximately 17 thousand incident cases of bronchopulmonary dysplasia were estimated in the 7MM. These cases are anticipated to increase by 2034 driven by the increasing number of premature births.
• In 2023, approximately 13 thousand incidence cases of bronchopulmonary dysplasia in the US were reported. These cases are expected to increase by 2034 due to increased prenatal factors such as maternal smoking, infections, and inadequate care.
• Among the EU4 and the UK, Germany had the highest incident population of bronchopulmonary dysplasia with approximately 930 cases, followed by France with 920 cases. On the other hand, Italy had the lowest incident population with nearly 390 cases in 2023.
• In the US, there were nearly 5 thousand cases of bronchopulmonary dysplasia in ≤750 g birth weight group preterm infants followed by approximately 5 thousand cases in 751-1000 g, 2 thousand cases in 1001-1250 g, and 709 cases in ≥1250 g in 2023. These cases are expected to increase by 2034.
• In the US, there were a total of nearly 5 thousand, 5 thousand and 3 thousand severity-specific cases of mild, moderate, and severe cases of bronchopulmonary dysplasia respectively, in 2023. As per DelveInsight's analysts, the severity-specific cases of bronchopulmonary dysplasia will increase by 2034 owing to the increasing incidence of premature babies in the US.
• As per the DelveInsight analysis, the total incident cases of bronchopulmonary dysplasia in Japan were approximately 442 cases, out of which there were 191, 76, and 175 severity-specific cases of mild, moderate, and severe bronchopulmonary dysplasia respectively, in 2023.
• Bronchopulmonary Dysplasia Companies such as Medipost Co, Oak Hill Bio/Takeda, Chiesi Farmaceutici, PNEUMOSTEM, Airway Therapeutics, Emmes Company, Medipost Co Ltd., Chiesi Pharmaceuticals, Mallinckrodt, Abbott, Shire, and others
• Bronchopulmonary Dysplasia Therapies such as PNEUMOSTEM®, OHB-607, CHF5633, Medipost, AT-100, Furosemide Cohort, PNEUMOSTEM®, Curosurf, Infasurf, palivizumab, rhIGF-I/rhIGFBP-3, and others

Stay ahead in the Bronchopulmonary Dysplasia Therapeutics Market with DelveInsight's Strategic Report @ Bronchopulmonary Dysplasia Market Outlook - https://www.delveinsight.com/sample-request/bronchopulmonary-dysplasia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Bronchopulmonary Dysplasia Epidemiology Segmentation:
• Total Incident cases of Bronchopulmonary Dysplasia in the 7MM
• Weight-specific cases of Bronchopulmonary Dysplasia in the 7MM
• Severity-specific cases of Bronchopulmonary Dysplasia in the 7MM

Download the report to understand which factors are driving Bronchopulmonary Dysplasia epidemiology trends @ Bronchopulmonary Dysplasia Epidemiology Forecast- https://www.delveinsight.com/sample-request/bronchopulmonary-dysplasia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Bronchopulmonary Dysplasia Market Outlook
Once bronchopulmonary dysplasia develops, the primary goal of the treatment of bronchopulmonary dysplasia is to provide adequate respiratory support and nutrition to promote optimal lung growth. Multiple pharmacologic and non-pharmacologic treatment strategies have been proposed to support survival, minimize further lung injury, and facilitate recovery. Despite advancements like prenatal steroids, surfactants, and improved resuscitation methods boosting premature infant survival, safeguarding their underdeveloped organs from the stress of life-saving measures at birth remains a challenge. Respiratory therapies span from noninvasive ventilator support to mechanical ventilation with a tracheostomy. Infants with mild bronchopulmonary dysplasia often require oxygen support solely to enhance lung function, without necessitating pharmacological intervention. Pharmacological treatments for bronchopulmonary dysplasia encompass bronchodilators, diuretics, antibiotics, surfactants, and corticosteroids. Although corticosteroids, with their anti-inflammatory properties, have been widely employed in bronchopulmonary dysplasia treatment or prevention, systemic steroid use is linked to significant short- and long-term adverse effects.

Bronchopulmonary Dysplasia Therapies and Key Companies
• PNEUMOSTEM®: Medipost Co
• OHB-607: Oak Hill Bio/Takeda
• CHF5633: Chiesi Farmaceutici
• Medipost: PNEUMOSTEM
• AT-100: Airway Therapeutics
• Furosemide Cohort: Emmes Company
• PNEUMOSTEM®: Medipost Co Ltd.
• Curosurf: Chiesi Farmaceuticials
• Infasurf : Mallinckrodt
• palivizumab: Abbott
• rhIGF-I/rhIGFBP-3: Shire

Discover more about therapies set to grab major Bronchopulmonary Dysplasia market share @ Bronchopulmonary Dysplasia Treatment Market- https://www.delveinsight.com/sample-request/bronchopulmonary-dysplasia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Bronchopulmonary Dysplasia Market Drivers
• Improved disease understanding
• Increase in Bronchopulmonary Dysplasia patient pool
• Biomarkers
• Limited late-stage drugs in the pipeline

Bronchopulmonary Dysplasia Market Barriers
• The discrepancy in Epidemiology Data
• Lack of adequate clinical data
• High use of Non-pharmacological therapy
• Limitations in Animal Models

Scope of the Bronchopulmonary Dysplasia Market Report
• Study Period: 2020-2034
• Coverage: 7MM
• Bronchopulmonary Dysplasia Companies: Medipost Co, Oak Hill Bio/Takeda, Chiesi Farmaceutici, PNEUMOSTEM, Airway Therapeutics, Emmes Company, Medipost Co Ltd., Chiesi Pharmaceuticals, Mallinckrodt, Abbott, Shire, and others
• Bronchopulmonary Dysplasia Therapies: PNEUMOSTEM®, OHB-607, CHF5633, Medipost, AT-100, Furosemide Cohort, PNEUMOSTEM®, Curosurf, Infasurf (ONY Inc.), palivizumab, rhIGF-I/rhIGFBP-3, and others
• Bronchopulmonary Dysplasia Therapeutic Assessment: Bronchopulmonary Dysplasia current marketed and Bronchopulmonary Dysplasia emerging therapies
• Bronchopulmonary Dysplasia Market Dynamics: Bronchopulmonary Dysplasia market drivers and Bronchopulmonary Dysplasia market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Bronchopulmonary Dysplasia Unmet Needs, KOL's views, Analyst's views, Bronchopulmonary Dysplasia Market Access and Reimbursement

To know more about Bronchopulmonary Dysplasia companies working in the treatment market, visit @ Bronchopulmonary Dysplasia Clinical Trials and Therapeutic Assessment- https://www.delveinsight.com/sample-request/bronchopulmonary-dysplasia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Contents
1. Bronchopulmonary Dysplasia Market Report Introduction
2. Executive Summary for Bronchopulmonary Dysplasia
3. SWOT analysis of Bronchopulmonary Dysplasia
4. Bronchopulmonary Dysplasia Patient Share (%) Overview at a Glance
5. Bronchopulmonary Dysplasia Market Overview at a Glance
6. Bronchopulmonary Dysplasia Disease Background and Overview
7. Bronchopulmonary Dysplasia Epidemiology and Patient Population
8. Country-Specific Patient Population of Bronchopulmonary Dysplasia
9. Bronchopulmonary Dysplasia Current Treatment and Medical Practices
10. Bronchopulmonary Dysplasia Unmet Needs
11. Bronchopulmonary Dysplasia Emerging Therapies
12. Bronchopulmonary Dysplasia Market Outlook
13. Country-Wise Bronchopulmonary Dysplasia Market Analysis (2020-2034)
14. Bronchopulmonary Dysplasia Market Access and Reimbursement of Therapies
15. Bronchopulmonary Dysplasia Market Drivers
16. Bronchopulmonary Dysplasia Market Barriers
17. Bronchopulmonary Dysplasia Appendix
18. Bronchopulmonary Dysplasia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

List of Top Selling Market Research Reports in 2025

Intraocular lens market- https://www.delveinsight.com/blog/top-companies-in-the-intraocular-lens-market
Urea cycle disorders market- https://www.delveinsight.com/blog/urea-cycle-disorder-market
Phototherapies for psoriasis market- https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
Vascular access devices market- https://www.delveinsight.com/report-store/vascular-access-device-market
NK cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Cardiac monitoring devices market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Lactose intolerance market- https://www.delveinsight.com/report-store/lactose-intolerance-market
Ventral hernia market- ttps://www.delveinsight.com/report-store/hernia-repair-devices-market
Medical marijuana market- https://www.delveinsight.com/report-store/medical-marijuana-market
Total knee arthroplasty market- https://www.delveinsight.com/report-store/knee-reconstruction-devices-market
Surgical energy instruments market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-and-adhesives-market
Baricose vein treatment devices market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Pouchitis market- https://www.delveinsight.com/report-store/pouchitis-market
Diabetic wound market- https://www.delveinsight.com/report-store/diabetic-wounds-market
Healthcare competitive benchmarking- https://www.delveinsight.com/consulting/competitive-benchmarking-services
Transcatheter treatment market- https://www.delveinsight.com/report-store/transcatheter-treatment-market
Indwelling catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Overactive bladder syndrome market- https://www.delveinsight.com/report-store/overactive-bladder-oab-market
Chronic neuropathic pain market- https://www.delveinsight.com/report-store/chronic-neuropathic-pain-market
Microscopy device market- https://www.delveinsight.com/report-store/microscopy-device-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.